دورية أكاديمية

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

التفاصيل البيبلوغرافية
العنوان: Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
المؤلفون: Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael W. N., Miller, Carole B., Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth O., Lyons, Roger M., Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Sun, Kang, Kantarjian, Hagop
المساهمون: Incyte Corporation
المصدر: Journal of Hematology & Oncology ; volume 10, issue 1 ; ISSN 1756-8722
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2017
مصطلحات موضوعية: Cancer Research, Oncology, Molecular Biology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1186/s13045-017-0417-z
DOI: 10.1186/s13045-017-0417-z.pdf
DOI: 10.1186/s13045-017-0417-z/fulltext.html
الإتاحة: https://doi.org/10.1186/s13045-017-0417-zTest
حقوق: http://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.BCF1D3E7
قاعدة البيانات: BASE